期刊
CHEMICO-BIOLOGICAL INTERACTIONS
卷 276, 期 -, 页码 121-126出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.cbi.2017.03.006
关键词
Tiaprofenic acid; Carbonyl reducing enzymes (CREs); AKR; Short-chain dehydrogenase/reductase; Carbonyl reductase; Reductive drug metabolism
资金
- Charles University in Prague [UNCE 204026/2012, SVV 260 294]
Tiaprofenic acid is a widely used anti-inflammatory drug; however, the reductive metabolism of tiaprofenic acid is not yet well understood. Here, we compared the reduction of tiaprofenic acid in microsomes and cytosol from the human liver. The microsomes exhibited lower K-m value toward tiaprofenic acid than the cytosol (K-m = 164 +/- 18 mu M vs. 569 +/- 74 mu M, respectively), whereas the cytosol showed higher specific activity during reduction than the microsomes (V-max = 728 +/- 52 pmol mg of protein(-1) min(-1) vs. 285 +/- 11 pmol mg of protein(-1) min(-1), respectively). Next, a panel of recombinant carbonyl reducing enzymes from AKR and SDR superfamilies has been studied to find the enzymes responsible for the cytosolic reduction of tiaprofenic acid. CBR1 was identified as the reductase of tiaprofenic acid with high specific activity (56,965 +/- 6741 pmol mg of protein(-1) min(-1)). Three other enzymes, AKR1A1, AKR1B10, and AKR1C4, were also able to reduce tiaprofenic acid, but with very low activity. Thus, CBR1 was shown to be a tiaprofenic acid reductase in vitro and was also suggested to be the principal tiaprofenic acid reductase in vivo. (C) 2017 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据